Skip to content
  • FAQ
  • Contact

FIP Capetown 2024

82ND FIP WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

  • Register
    Registration fees Registration guidelines Registration forms
  • Abstracts
    Call for abstracts Guidelines for poster presenters
  • Programme
    Programme per day (in SAST) Programme overview (in SAST) General events Social events Programme theme Continuing Professional Development (CPD) points Young Scientist Award
  • Info
    Latest information Cape Town Venue Sightseeing Tours Professional Tours Important dates Travel advice Pharmacy in South Africa
  • Housing & Visa
    Accommodation Visa information for South Africa
  • Organisation
    FIP Congress partner Supporting (member) organisations and associations
  • Partners & exhibitors
    General information Confirmed partners & exhibitors Exhibitors floorplan
  • Media
    Banners and adverts Press registration Media Partners

RFTU-14 - Rapid fire session from selected oral abstracts

Roof Terrace room Tuesday 3 September 2024, 14:30-16:00

    (SEC) Community pharmacy

    • RFTU-1404 - Right person, right place, right time – Pharmacist prescribing in community pharmacy in Great Britain
    • RFTU-1405 - Community pharmacy-based HbA1C screening for early detection of diabetes and pre-diabetes
    • RFTU-1406 - Belgian community pharmacists compound tapering schemes for long term benzodiazepine users

    (SEC) Social and administrative pharmacy

    • RFTU-1401 - Exploring the impact of entrepreneurial orientation on proposition and adoption of cognitive pharmacy services in French pharmacies
    • RFTU-1402 - Investigating postpartum depression in first-time mothers using PRAMS data: Race, ethnicity, age, and geographic analysis
    • RFTU-1403 - Analyzing factors influencing drug prices in public pooled procurement: A focus on market competition

    (SIG) Drug delivery and manufacturing

    • RFTU-1407 - Hybrid biopolymer/bioceramic 3D-Printed scaffolds embedded with Doxorubicin Nanoparticulate Systems for local treatment of osteosarcoma

    Follow us

    fip © Copyright International Pharmaceutical Federation 2025
    • Privacy statement
    • Disclaimer
    • Scroll to top